GB2349335A - Compositions - Google Patents

Compositions

Info

Publication number
GB2349335A
GB2349335A GB0016470A GB0016470A GB2349335A GB 2349335 A GB2349335 A GB 2349335A GB 0016470 A GB0016470 A GB 0016470A GB 0016470 A GB0016470 A GB 0016470A GB 2349335 A GB2349335 A GB 2349335A
Authority
GB
United Kingdom
Prior art keywords
contrast agents
particulate compositions
compositions
vesicles
enhance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0016470A
Other versions
GB0016470D0 (en
Inventor
Gregory Lynn Mcintire
Edward Richard Bacon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Publication of GB0016470D0 publication Critical patent/GB0016470D0/en
Publication of GB2349335A publication Critical patent/GB2349335A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Water-soluble iodinated X-ray contrast agents can stabilise certain particulate compositions comprising vesicles or liquid droplets for thermal sterilisation. Such contrast agents also enhance the physical stability of particulate compositions to settling during storage.
GB0016470A 1998-10-09 1999-10-08 Compositions Withdrawn GB2349335A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9822158.3A GB9822158D0 (en) 1998-10-09 1998-10-09 Compositions
PCT/GB1999/003344 WO2000021577A2 (en) 1998-10-09 1999-10-08 Compositions

Publications (2)

Publication Number Publication Date
GB0016470D0 GB0016470D0 (en) 2000-08-23
GB2349335A true GB2349335A (en) 2000-11-01

Family

ID=10840358

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9822158.3A Ceased GB9822158D0 (en) 1998-10-09 1998-10-09 Compositions
GB0016470A Withdrawn GB2349335A (en) 1998-10-09 1999-10-08 Compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB9822158.3A Ceased GB9822158D0 (en) 1998-10-09 1998-10-09 Compositions

Country Status (3)

Country Link
AU (1) AU6217199A (en)
GB (2) GB9822158D0 (en)
WO (1) WO2000021577A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6809104B2 (en) 2001-05-04 2004-10-26 Tularik Inc. Fused heterocyclic compounds
EP1392298B1 (en) 2001-05-04 2009-02-18 Amgen Inc. Fused heterocyclic compounds
CN1335182A (en) * 2001-08-08 2002-02-13 华中科技大学 Insulin spray for oral cavity and its prepn process
US20040067221A1 (en) * 2002-05-22 2004-04-08 Medtronic, Inc. Cell delivery fluid for prevention of cell settling in delivery system
US20050287125A1 (en) * 2002-05-22 2005-12-29 Medtronic, Inc. Cell delivery fluid for prevention of cell settling in delivery system
KR20050103184A (en) 2002-11-06 2005-10-27 암젠 인코포레이션 Fused heterocyclic compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2613172A (en) * 1949-08-10 1952-10-07 American Cystoscope Makers Inc X-ray contrast compositions
WO1980001244A1 (en) * 1978-12-19 1980-06-26 Bykgulden Lomberg Chem Fab X-ray contrast media solutions
EP0128578A1 (en) * 1983-06-14 1984-12-19 Byk Gulden Lomberg Chemische Fabrik GmbH Ethanolic suspensions of contrast agents
NZ248650A (en) * 1992-12-15 1994-08-26 Sterling Winthrop Inc Diagnostic image enhancing void-containing organic particle; preparation by co-precipitation of two organic substances and leaching out one of them
GB9417941D0 (en) * 1994-09-06 1994-10-26 Nycomed Imaging As Improvements in or relating to contrast agents
WO1997006132A1 (en) * 1995-08-10 1997-02-20 Nanosystems L.L.C. Triiodoalkylphenyl esters as novel x-ray contrast agents
KR970069028A (en) * 1996-04-01 1997-11-07 김은영 Manufacturing method of chemical color exclusive emulsion
GB9705340D0 (en) * 1997-03-14 1997-04-30 Nycomed Imaging As Compositions
WO1998048847A1 (en) * 1997-04-25 1998-11-05 Nycomed Imaging As Nanoparticle composition containing iodinated x-ray contrast agent as stabilizer for thermal sterilization

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NOT YET ADVISED *

Also Published As

Publication number Publication date
AU6217199A (en) 2000-05-01
GB0016470D0 (en) 2000-08-23
WO2000021577A2 (en) 2000-04-20
GB9822158D0 (en) 1998-12-02
WO2000021577A3 (en) 2000-07-27

Similar Documents

Publication Publication Date Title
HUP9903174A2 (en) Pharmaceutical composition comprising coenzyme q10
ES2162951T3 (en) STABILIZATION OF PROSTAGLANDINA COMPOSITIONS.
IL105511A (en) 2,4-dioxoimidazolidine derivatives their preparation and pharmaceutical compositions containing them
ZA986489B (en) Stable liquid composition comprising high levels of emollients.
EP0680694A3 (en) Compositions of fluorescent biocides for use in aqueous systems.
DE3176125D1 (en) 1-carboxyalkanoylindolin-2-carboxylic acids and derivatives thereof, processes for their preparation, and pharmaceutical compositions containing these compounds
HU9302439D0 (en) Imidazole derivatives
CO5670348A2 (en) HYDROPHOBO SYSTEM FOR WHITENING TEETH AND METHODS OF USE
ATE175657T1 (en) POLYALKOXYLATED TERPENE DERIVATIVES AND COMPOSITIONS CONTAINING THEM
ZA979550B (en) Method for the preparation of methylidene malonate nanoparticles, nanoparticles which optionally contain one or more biologically active molecules, and pharmaceutical compositions containing them.
ATE421337T1 (en) ADENOVIRUS FORMULATIONS FOR GENE THERAPY
IL117144A0 (en) Pharmaceutical compositions containing nucleic acids
NZ333475A (en) Microemulsion all purpose liquid cleaning compositions containing 0.05% to 5.0% of an acaricidal agent
ATE429210T1 (en) ORAL LIQUID COMPOSITIONS
AU2002220690A1 (en) Use of liquids containing 1,1,1,3,3-pentafluorobutane as cooling agents or heat carriers
BG104930A (en) 2-phenyl-1-[2-(-aminoethoxy)-benzyl]-indole in combination with estrogens
GB2349335A (en) Compositions
UA37187C2 (en) aqueous solution of methylolguidantoins, substantially anhydrous composition methylolguidantoins and method for preparation thereof, mixture containing liquid medium favorable<tab>for microbes growth, method for decelaration of microbes growth
ES2180319T3 (en) USE OF METHYLENBISOXAZOLIDINE DERIVATIVES AND COMPOSITIONS OF THE SAME.
TR200101493T2 (en) Eletriptan hydrobromide monohydrate
ATE245028T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRIMEGESTONE
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
IL135634A0 (en) 5-htif agonists
CA2330808A1 (en) Method for preparing an antimicrobial composition
ES2054827T3 (en) USE OF ALKYL PHOSPHATES FOR THE STABILIZATION OF TIXOTROPIC COMPOSITIONS.

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)